Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
345.00    0.00 (0.00%)
Bid:
330.00
Ask:
360.00
Spread: 30.00 (9.091%)
Market Cap: £32.96m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Directors' option interests

31 Mar 2015 12:44

RNS Number : 0101J
Cropper(James) PLC
31 March 2015
Β 

31 March 2015

James Cropper plc

(the "Company")

Β 

Directors' option interests

Β 

The Company provides the following update of the interest of the directors in options over ordinary shares of 25p each in the Company ("Options").

Β 

The trustees of the James Cropper Employee Trust of James Cropper EBT Ltd approved grant awards to the following directors under the terms of The James Cropper Plc 2008 Long Term Incentive Plan (the "LTIP" or the "Plan"), as set out below.

Β 

Grant date

20/08/2012

16/11/2012

23/07/2013

21/01/2014

04/08/2014

Award ref price

184.0p

174.65p

253.4p

361.4p

382.8p

Β 

Options vested

Β 

Total LTIP Options

Director

MAJ Cropper

4,673

6,022

10,695

IM Maddock

1,808 *

7,868

9,676

M Thompson

13,000 *

11,601

7,868

32,469

KD Watson

2,252

8,832

11,084

PI Wild

19,324

32,796

22,242

74,362

PJ Willink

16,000

10,978

7,868

34,846

* LTIP Options granted prior to appointment to Board

Β 

The LTIP Options are subject to the achievement of pre-determined performance conditions and become exercisable at the end of a three year holding period from the date of the award. Further details are set out in the appendix below.

Β 

In addition, the following directors hold Options under the Company's save-as-you-earn ("SAYE") scheme, exercisable at 199.52p per share within six month of maturity, as set out below.

Β 

Term

(from 1 September 2013)

3.25 years

5.25 years

Total SAYE Options

Director

IM Maddock

4,360

4,360

PI Wild

4,510

4,510

PJ Willink

902

902

Β 

Enquiries:

David Carey, Company Secretary

Robert Finlay, David Coaten

James Cropper PLC (AIM:CRPR)

Westhouse Securities Limited

Tel: +44 (0) 1539 722002

Tel: +44 (0) 207 601 6100

www.cropper.com

www.westhousesecurities.com

Β 

Appendix - Long-Term Incentive Plan performance conditions

Β 

Under the Plan, awards to acquire ordinary shares in the Company can be made to executive directors and employees of the Company and its subsidiaries selected by the Remuneration Committee.

Awards made during the financial year to 28 March 2015 under the Plan to executive directors were as follows:

Number at 29 March 2014

Number granted in period

Mid-market price (Β£) of options awarded

Number exercised in period

Options lapsed in period

Number at 28 March 2015

P I Wild

52,120

22,242

Β£3.828

-

-

74,362

M A J Cropper

4,673

6,022

Β£3.828

-

-

10,695

J M Denman*

39,601

-

-

-

-

39,601

-

N A Read*

39,029

-

-

39,029

-

P J Willink

38,978

7,868

Β£3.828

-

12,000

34,846

I M Maddock

1,808

7,868

Β£3.828

-

-

9,676

M Thompson

34,601

7,868

Β£3.828

-

10,000

32,469

K D Watson

2,252

8,832

Β£3.828

-

-

11,084

* previous directors

The number of options that can be awarded to any participant in a financial year under the Plan, determined by reference to Company's 20 day average mid-market share price at the time of the award, is limited to a maximum of 50% of the participant's basic salary.

The LTIP awards are subject to the achievement of certain performance conditions, specific to each director, as set out below:

Earnings per share conditions

EBITDA targets conditions

Percentage of Award

Percentage of Award

P I Wild

60%

40%

M A J Cropper

60%

40%

P J Willink

100%

-

I M Maddock

100%

-

M Thompson

100%

-

K D Watson

100%

-

Β 

(i) Earnings per share conditions

- Awards will vest in full on the third anniversary of the Award provided the growth in the Company's earnings per share, adjusted for IFRS pension adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested exceed the increase in retail price index plus 10% per annum;

Β 

- Awards will vest at 10% on the third anniversary of the Award if the growth in the Company's earnings per share, adjusted for IFRS pension adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested exceed the increase in retail price index plus 2.5% per annum;

Β 

- Awards will vest proportionally between 10% and 100% on the third anniversary of the Award if the growth in the Company's earnings per share, adjusted for IFRS adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested exceed the increase in retail price index by more than 2.5% but less than 10% per annum; and

Β 

- Awards will lapse on the third anniversary of the Award if the growth in the Company's earnings per share, adjusted for IFRS pension adjustments, between the preceding financial year end when the award was granted and the preceding financial year end when the grant is vested, does not exceed the increase in retail price plus 2.5% per annum.

Β 

(ii) EBITDA target conditions

- Awards will vest in full on the third anniversary of the Award if the third year EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been met or exceeded;

Β 

- Awards will vest at 30% on the third anniversary of the Award if at least 95% but less than 100% of the third year EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been met or exceeded;

Β 

- Awards will vest at 20% on the third anniversary of the Award if a least 90% but less than 95% of the EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been met or exceeded; and

Β 

- Awards will lapse on the third anniversary of the Award if less than 90% of the EBITDA target as set out in the Company's 3 Year Business Plan approved in the year that the award was granted has been achieved.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSFFLFXEXFZBBX
Date   Source Headline
14th Apr 20267:00 amRNSFull Year Trading Update
27th Mar 20262:50 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RCollaboration with Hexcel on Composite Recycling
5th Dec 20259:34 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSPCA Shareholdings
17th Nov 20257:00 amRNSInterim Results
5th Nov 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 20257:00 amRNSCorrection: PDMR and PCA Shareholdings
17th Oct 20254:12 pmRNSPDMR and PCA Shareholdings
15th Sep 20257:00 amRNSDirector/PDMR Shareholding
3rd Sep 20253:34 pmRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSGrant of Awards under Long-Term Incentive Plan
17th Jul 20257:00 amRNSFull Year Results
15th Jul 20257:00 amRNSNotice of Full Year Results
7th Jul 20257:00 amRNSTrading and Paper & Packaging Customer Update
23rd Jun 20257:00 amRNS-RRecording of Capital Markets Event Presentation
18th Jun 20257:00 amRNSStrategy Update and Capital Markets Event
9th Jun 20257:00 amRNSRevised Terms Agreed for UK Banking Facility
5th Jun 20257:00 amRNS-RNotice of Capital Markets Event
19th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSFull Year Trading Update
1st May 20259:14 amRNS€1.75m sale of non-core IP assets
1st Apr 20257:00 amRNS-RStrategic Collaboration with HOERBIGER
14th Feb 20253:32 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSPDMR and PCA Shareholding
30th Jan 20257:00 amRNSConfirmation of Chief Executive Officer Succession
7th Jan 20257:00 amRNSDirectorate Change
23rd Dec 20249:21 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSInterim Results
4th Nov 202412:03 pmRNSNotification of Major Holdings
1st Nov 20241:05 pmRNSNotice of Interim Results
29th Oct 20247:00 amRNSChief Executive Officer Succession
10th Oct 202410:14 amRNSDirector/PDMR Shareholding
8th Oct 20244:39 pmRNSDirector/PDMR Shareholding
10th Sep 20243:19 pmRNSGrant of Awards under Long-Term Incentive Plan
4th Sep 20244:32 pmRNSResult of Annual General Meeting
4th Sep 20247:00 amRNSAGM Trading Update
5th Aug 202411:56 amRNSNotice of Annual General Meeting
23rd Jul 20247:00 amRNSFull Year Results
22nd Jul 20249:43 amRNSDirectorate Changes
10th Jul 20247:00 amRNSNotice of Full Year Results
14th Jun 202411:00 amRNSAgreement of Bank Covenant Amendments
23rd May 20247:00 amRNSAppointment of MD, Advanced Materials
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.